STOCKSBiotech Stock Bubble Talk Deflated By Cost-Conscious BuyersBy David SobekOct 2, 2013 8:30 AM EDT
MARKETSTrade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's "Water-Logged And Getting Wetter" StockBy Marissa GoodbodySep 30, 2013 4:05 PM EDT
JIM CRAMERCramer's 'Mad Money' Recap: A Market Too Good to IgnoreBy Scott RuttAug 26, 2013 8:23 PM EDT
MARKETSOnyx Pharmaceuticals Inc. (ONXX): Today's Featured Drugs WinnerBy TheStreet WireAug 26, 2013 5:00 PM EDT
MERGERS AND ACQUISITIONSThe Deal: Amgen Soars on $10.4B Onyx DealBy The DealAug 26, 2013 11:35 AM EDT
STOCKSAmgen Regains Biotech Growth Cred With $10B Onyx AcquisitionBy Adam FeuersteinAug 26, 2013 11:06 AM EDT
MARKETSTrade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's Pre-Market Mover With Heavy Volume StockBy Jamie HodgeAug 26, 2013 8:00 AM EDT
STOCKSOnyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen TakeoutBy Adam FeuersteinAug 25, 2013 8:21 PM EDT
MERGERS AND ACQUISITIONSAmgen and Onyx Pharmaceuticals Reported to be Near DealBy TheStreet StaffAug 25, 2013 1:06 PM EDT
MARKETSStock Futures Get Lift From Overseas Data; Jobless Claims RiseBy Andrea TseAug 22, 2013 9:06 AM EDT
MARKETSTrade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's Post-Market Leader StockBy Scott OlsonAug 21, 2013 5:41 PM EDT
